Y
Yutaka Takahashi
Researcher at University of Texas MD Anderson Cancer Center
Publications - 14
Citations - 2699
Yutaka Takahashi is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Metastasis & Vascular endothelial growth factor. The author has an hindex of 10, co-authored 14 publications receiving 2661 citations.
Papers
More filters
Journal Article
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
TL;DR: The hypothesis that VEGF is an important angiogenic factor in primary and metastatic human colon cancer is supported and expression and vessel counts may aid in predicting patients at risk for metastasis from colon cancer.
Journal ArticleDOI
Vessel Counts and Expression of Vascular Endothelial Growth Factor as Prognostic Factors in Node-Negative Colon Cancer
Yutaka Takahashi,Susan L. Tucker,Yasuhiko Kitadai,Aaryan N. Koura,Corazon D. Bucana,Karen R. Cleary,Lee M. Ellis +6 more
TL;DR: Vessel count and expression of VEGF may be useful for predicting distant recurrence in patients with node-negative colon cancer.
Journal ArticleDOI
Platelet-Derived Endothelial Cell Growth Factor in Human Colon Cancer Angiogenesis: Role of Infiltrating Cells
Yutaka Takahashi,Corazon D. Bucana,Wenbiao Liu,Junya Yoneda,Yasuhiko Kitadai,Karen R. Cleary,Lee M. Ellis +6 more
TL;DR: PD-ECGF expression in human colon cancer specimens is associated with vessel count and may be responsible for tumor vascularity in those tumors with low VEGF expression.
Journal Article
Significance of Vessel Count and Vascular Endothelial Growth Factor and Its Receptor (KDR) in Intestinal-type Gastric Cancer'
Yutaka Takahashi,Karen R. Cleary,Masayoshi Mai,Yasuhiko Kitadai,Corazon D. Bucana,Lee M. Ellis +5 more
TL;DR: The correlation of V EGF expression and its endothelial receptor with vessel count and stage of disease suggests that VEGF is at least one of the factors responsible for the induction of angiogenesis in intestinal-type gastric cancer.
Journal ArticleDOI
Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.
TL;DR: Results showed that targeting the VEGF receptor/ligand system is a rational approach to inhibiting tumor growth and prolonging survival.